Trade Mitsui Chemicals, Inc. - 4183 CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 27.2 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.011022% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.011201% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | JPY | ||||||||
Margin | 5% | ||||||||
Stock exchange | Japan | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Mitsui Chemicals Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 4520 |
Open* | 4448.3 |
1-Year Change* | 35.98% |
Day's Range* | 4396.4 - 4489.3 |
52 wk Range | 2,908.00-4,493.00 |
Average Volume (10 days) | 667.53K |
Average Volume (3 months) | 16.44M |
Market Cap | 868.45B |
P/E Ratio | 13.93 |
Shares Outstanding | 190.14M |
Revenue | 1,752.12B |
EPS | 310.32 |
Dividend (Yield %) | 3.00648 |
Beta | 1.41 |
Next Earnings Date | Feb 7, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2024 | 4451.6 | 21.2 | 0.48% | 4430.4 | 4506.8 | 4405.4 |
Mar 27, 2024 | 4520.0 | 68.8 | 1.55% | 4451.2 | 4555.1 | 4428.3 |
Mar 26, 2024 | 4434.4 | 14.0 | 0.32% | 4420.4 | 4464.1 | 4412.3 |
Mar 25, 2024 | 4432.3 | -60.7 | -1.35% | 4493.0 | 4524.2 | 4427.3 |
Mar 22, 2024 | 4522.0 | 11.9 | 0.26% | 4510.1 | 4583.0 | 4510.1 |
Mar 21, 2024 | 4523.2 | -4.9 | -0.11% | 4528.1 | 4548.3 | 4490.1 |
Mar 19, 2024 | 4521.2 | 84.8 | 1.91% | 4436.4 | 4535.1 | 4416.3 |
Mar 18, 2024 | 4377.6 | 69.9 | 1.62% | 4307.7 | 4395.9 | 4304.6 |
Mar 15, 2024 | 4244.9 | 3.1 | 0.07% | 4241.8 | 4278.7 | 4211.9 |
Mar 14, 2024 | 4241.1 | 37.1 | 0.88% | 4204.0 | 4271.9 | 4167.0 |
Mar 13, 2024 | 4166.0 | -46.0 | -1.09% | 4212.0 | 4219.0 | 4129.1 |
Mar 12, 2024 | 4163.1 | 81.9 | 2.01% | 4081.2 | 4163.1 | 4048.3 |
Mar 11, 2024 | 4144.2 | -56.7 | -1.35% | 4200.9 | 4222.3 | 4097.2 |
Mar 8, 2024 | 4254.1 | 13.0 | 0.31% | 4241.1 | 4280.0 | 4220.9 |
Mar 7, 2024 | 4188.0 | -73.7 | -1.73% | 4261.7 | 4265.3 | 4176.0 |
Mar 6, 2024 | 4236.9 | 56.4 | 1.35% | 4180.5 | 4246.2 | 4180.5 |
Mar 5, 2024 | 4165.1 | -43.2 | -1.03% | 4208.3 | 4208.3 | 4158.0 |
Mar 4, 2024 | 4248.3 | -5.7 | -0.13% | 4254.0 | 4294.6 | 4242.8 |
Mar 1, 2024 | 4268.8 | 78.6 | 1.88% | 4190.2 | 4288.7 | 4184.9 |
Feb 29, 2024 | 4148.1 | 29.8 | 0.72% | 4118.3 | 4166.0 | 4074.2 |
Mitsui Chemicals, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Friday, May 10, 2024 | ||
Time (UTC) 04:00 | Country JP
| Event Full Year 2024 Mitsui Chemicals Inc Earnings Release Full Year 2024 Mitsui Chemicals Inc Earnings ReleaseForecast -Previous - |
Wednesday, June 26, 2024 | ||
Time (UTC) 01:00 | Country JP
| Event Mitsui Chemicals Inc Annual Shareholders Meeting Mitsui Chemicals Inc Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 1879550 | 1612690 | 1211720 | 1349520 | 1482910 |
Revenue | 1879550 | 1612690 | 1211720 | 1349520 | 1482910 |
Cost of Revenue, Total | 1498050 | 1233950 | 917883 | 1051140 | 1166580 |
Gross Profit | 381493 | 378740 | 293842 | 298383 | 316332 |
Total Operating Expense | 1750550 | 1465380 | 1133650 | 1284950 | 1387220 |
Selling/General/Admin. Expenses, Total | 284589 | 239356 | 211980 | 226592 | 187109 |
Research & Development | 35796 | ||||
Unusual Expense (Income) | -11656 | 12124 | 9596 | 6819 | -2267 |
Operating Income | 128998 | 147310 | 78074 | 64569 | 95694 |
Interest Income (Expense), Net Non-Operating | -1068 | -1626 | -2659 | -876 | 13426 |
Gain (Loss) on Sale of Assets | -3605 | ||||
Other, Net | -10652 | -4410 | -1172 | -2869 | -218 |
Net Income Before Taxes | 117278 | 141274 | 74243 | 60824 | 105297 |
Net Income After Taxes | 90138 | 118551 | 64219 | 42619 | 86523 |
Minority Interest | -7202 | -8561 | -6346 | -8649 | -10408 |
Net Income Before Extra. Items | 82936 | 109990 | 57873 | 33970 | 76115 |
Net Income | 82936 | 109990 | 57873 | 33970 | 76115 |
Income Available to Common Excl. Extra. Items | 82936 | 109990 | 57873 | 33970 | 76115 |
Income Available to Common Incl. Extra. Items | 82936 | 109990 | 57873 | 33970 | 76115 |
Diluted Net Income | 82936 | 109990 | 57873 | 33970 | 76115 |
Diluted Weighted Average Shares | 192.35 | 194.517 | 194.202 | 194.649 | 197.394 |
Diluted EPS Excluding Extraordinary Items | 431.173 | 565.453 | 298.004 | 174.52 | 385.599 |
Dividends per Share - Common Stock Primary Issue | 120 | 115 | 100 | 100 | 100 |
Diluted Normalized EPS | 384.598 | 617.757 | 340.745 | 199.067 | 394.467 |
Interest Expense (Income) - Net Operating | -21693 | -25819 | -5989 | -4512 | |
Other Operating Expenses, Total | 1255 | 5769 | 181 | 4915 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 450636 | 477834 | 474964 | 476113 | 447609 |
Revenue | 450636 | 477834 | 474964 | 476113 | 447609 |
Cost of Revenue, Total | 372988 | 377617 | 375923 | 371526 | 352337 |
Gross Profit | 77648 | 100217 | 99041 | 104587 | 95272 |
Total Operating Expense | 428656 | 443324 | 445405 | 433164 | 436325 |
Selling/General/Admin. Expenses, Total | 75357 | 70624 | 70100 | 68508 | 70185 |
Interest Expense (Income) - Net Operating | -3246 | -4259 | -5178 | -9010 | -3835 |
Unusual Expense (Income) | -18067 | -483 | 4652 | 2242 | 17138 |
Other Operating Expenses, Total | 1624 | -175 | -92 | -102 | 500 |
Operating Income | 21980 | 34510 | 29559 | 42949 | 11284 |
Interest Income (Expense), Net Non-Operating | -4889 | -4977 | 276 | -2130 | 411 |
Other, Net | |||||
Net Income Before Taxes | 17091 | 29533 | 29835 | 40819 | 11695 |
Net Income After Taxes | 18501 | 23061 | 18625 | 29951 | 11034 |
Minority Interest | -511 | -2468 | -2264 | -1959 | -1111 |
Net Income Before Extra. Items | 17990 | 20593 | 16361 | 27992 | 9923 |
Net Income | 17990 | 20593 | 16361 | 27992 | 9923 |
Income Available to Common Excl. Extra. Items | 17990 | 20593 | 16361 | 27992 | 9923 |
Income Available to Common Incl. Extra. Items | 17990 | 20593 | 16361 | 27992 | 9923 |
Diluted Net Income | 17990 | 20593 | 16361 | 27992 | 9923 |
Diluted Weighted Average Shares | 190.264 | 192.555 | 193.344 | 193.235 | 193.236 |
Diluted EPS Excluding Extraordinary Items | 94.5529 | 106.946 | 84.621 | 144.86 | 51.3516 |
Dividends per Share - Common Stock Primary Issue | 60 | 0 | 60 | 0 | 60 |
Diluted Normalized EPS | 32.8305 | 104.987 | 99.6413 | 153.373 | 135.028 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 1094290 | 1033440 | 787572 | 781834 | 786677 |
Cash and Short Term Investments | 262719 | 224648 | 223163 | 201376 | 111056 |
Cash & Equivalents | 185377 | 179754 | 193585 | 163983 | 111056 |
Total Receivables, Net | 376356 | 386352 | 290938 | 284992 | 365161 |
Accounts Receivable - Trade, Net | 339843 | 357221 | 274902 | 261497 | 309873 |
Total Inventory | 441949 | 369009 | 258814 | 284306 | 301890 |
Other Current Assets, Total | 6988 | 47479 | 9616 | 6765 | 8570 |
Total Assets | 2068200 | 1934960 | 1558120 | 1530520 | 1501070 |
Property/Plant/Equipment, Total - Net | 600887 | 553584 | 501960 | 499650 | 443063 |
Property/Plant/Equipment, Total - Gross | 2030730 | 1985550 | 1836070 | 1799940 | 1637100 |
Accumulated Depreciation, Total | -1429840 | -1431970 | -1334110 | -1300290 | -1194030 |
Goodwill, Net | 19338 | 17981 | 1123 | 1476 | 5061 |
Intangibles, Net | 48137 | 45341 | 19678 | 24759 | 24324 |
Long Term Investments | 229123 | 210460 | 178194 | 173752 | 165199 |
Other Long Term Assets, Total | 76432 | 74154 | 69598 | 49044 | 76750 |
Total Current Liabilities | 695444 | 706569 | 466305 | 485674 | 458758 |
Accounts Payable | 161197 | 173032 | 117750 | 117920 | 163908 |
Accrued Expenses | 175 | ||||
Notes Payable/Short Term Debt | 324120 | 297437 | 162182 | 179829 | 102733 |
Current Port. of LT Debt/Capital Leases | 44343 | 49178 | 54539 | 52964 | 57997 |
Other Current Liabilities, Total | 165784 | 186922 | 131834 | 134961 | 133945 |
Total Liabilities | 1281380 | 1222310 | 950204 | 1001300 | 949159 |
Total Long Term Debt | 369786 | 319471 | 293495 | 313237 | 321288 |
Long Term Debt | 369786 | 319471 | 293495 | 313237 | 321288 |
Deferred Income Tax | 35162 | 28133 | 27834 | 23017 | 11471 |
Minority Interest | 96476 | 94468 | 74236 | 80487 | 79824 |
Other Liabilities, Total | 84508 | 73670 | 88334 | 98880 | 77818 |
Total Equity | 786827 | 712654 | 607921 | 529220 | 551915 |
Common Stock | 125572 | 125414 | 125331 | 125298 | 125205 |
Additional Paid-In Capital | 57778 | 69866 | 74009 | 79320 | 89406 |
Retained Earnings (Accumulated Deficit) | 575125 | 516098 | 424084 | 359794 | 348202 |
Treasury Stock - Common | -32704 | -34932 | -24900 | -39254 | -29869 |
Unrealized Gain (Loss) | 21421 | ||||
Other Equity, Total | 61056 | 36208 | 9397 | 4062 | -2450 |
Total Liabilities & Shareholders’ Equity | 2068200 | 1934960 | 1558120 | 1530520 | 1501070 |
Total Common Shares Outstanding | 190.066 | 193.236 | 195.944 | 191.051 | 195.057 |
Short Term Investments | 77342 | 44894 | 29578 | 37393 | |
Prepaid Expenses | 6274 | 5957 | 5041 | 4395 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1082520 | 1078870 | 1094290 | 1132300 | 1131380 |
Cash and Short Term Investments | 244019 | 212227 | 262719 | 234673 | 253049 |
Cash & Equivalents | 202563 | 169048 | 186310 | 193408 | 208260 |
Short Term Investments | 41456 | 43179 | 76409 | 41265 | 44789 |
Total Receivables, Net | 319387 | 318876 | 352181 | 379530 | 370019 |
Accounts Receivable - Trade, Net | 319387 | 318876 | 352181 | 379530 | 370019 |
Total Inventory | 441036 | 449087 | 441949 | 455309 | 451270 |
Other Current Assets, Total | 78081 | 98678 | 37437 | 62787 | 57042 |
Total Assets | 2104350 | 2062840 | 2068200 | 2085710 | 2080210 |
Property/Plant/Equipment, Total - Net | 625412 | 598893 | 600887 | 593483 | 585115 |
Goodwill, Net | 20877 | 19524 | 19338 | 19636 | 18130 |
Intangibles, Net | 53152 | 50098 | 48137 | 46683 | 45589 |
Long Term Investments | 239111 | 231808 | 229123 | 226398 | 237177 |
Other Long Term Assets, Total | 83278 | 83646 | 76432 | 67207 | 62821 |
Total Current Liabilities | 681494 | 675043 | 695444 | 754833 | 744574 |
Accounts Payable | 154355 | 137705 | 164267 | 186395 | 188866 |
Notes Payable/Short Term Debt | 0 | 0 | 324120 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 345355 | 371754 | 44343 | 400938 | 368079 |
Other Current Liabilities, Total | 181784 | 165584 | 162714 | 167500 | 187629 |
Total Liabilities | 1273040 | 1253500 | 1281380 | 1320000 | 1303940 |
Total Long Term Debt | 372342 | 362959 | 369786 | 353735 | 346469 |
Long Term Debt | 372342 | 362959 | 369786 | 353735 | 346469 |
Deferred Income Tax | 41541 | 39260 | 35162 | 30204 | 29416 |
Minority Interest | 98338 | 98278 | 96476 | 97079 | 97205 |
Other Liabilities, Total | 79330 | 77964 | 84508 | 84144 | 86281 |
Total Equity | 831308 | 809333 | 786827 | 765711 | 776267 |
Common Stock | 125738 | 125572 | 125572 | 125572 | 125572 |
Additional Paid-In Capital | 57945 | 57778 | 57778 | 57778 | 70024 |
Retained Earnings (Accumulated Deficit) | 588256 | 577386 | 575125 | 549631 | 537654 |
Treasury Stock - Common | -32723 | -32713 | -32704 | -27679 | -34938 |
Other Equity, Total | 92092 | 81310 | 61056 | 44857 | 61797 |
Total Liabilities & Shareholders’ Equity | 2104350 | 2062840 | 2068200 | 2085710 | 2080210 |
Total Common Shares Outstanding | 190.141 | 190.064 | 190.066 | 191.722 | 193.344 |
Unrealized Gain (Loss) | 15552 | 16158 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Net income/Starting Line | 117278 | 141274 | 74243 | 60824 | 105297 |
Cash From Operating Activities | 101241 | 92584 | 174323 | 142232 | 109492 |
Cash From Operating Activities | 92080 | 84222 | 76621 | 76009 | 48853 |
Amortization | 651 | ||||
Non-Cash Items | -15519 | -16634 | 2782 | -2582 | -23624 |
Cash Taxes Paid | 34394 | 17036 | 7764 | 19212 | 17124 |
Cash Interest Paid | 5889 | 3972 | 4705 | 5589 | 5507 |
Changes in Working Capital | -92598 | -116278 | 20677 | 7981 | -21685 |
Cash From Investing Activities | -106340 | -205234 | -77555 | -109112 | -64255 |
Capital Expenditures | -137861 | -116216 | -76581 | -99771 | -55755 |
Other Investing Cash Flow Items, Total | 31521 | -89018 | -974 | -9341 | -8500 |
Cash From Financing Activities | 2542 | 89222 | -68956 | -6365 | -14134 |
Financing Cash Flow Items | -22842 | -14873 | -3466 | -6700 | -6118 |
Total Cash Dividends Paid | -24161 | -20527 | -19349 | -19509 | -18878 |
Issuance (Retirement) of Stock, Net | -10018 | -10031 | -688 | -9369 | -10028 |
Issuance (Retirement) of Debt, Net | 59563 | 134653 | -45453 | 29213 | 20890 |
Foreign Exchange Effects | 7715 | 8593 | 3604 | -1673 | -92 |
Net Change in Cash | 5158 | -14835 | 31416 | 25082 | 31011 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 117278 | 100187 | 70654 | 40819 | 141274 |
Cash From Operating Activities | 101241 | 44084 | 21911 | -10642 | 92584 |
Cash From Operating Activities | 92080 | 68800 | 44945 | 21842 | 84222 |
Non-Cash Items | -15519 | -12867 | -9532 | -7036 | -16634 |
Cash Taxes Paid | 34394 | 34478 | 21686 | 14051 | 17036 |
Cash Interest Paid | 5889 | 4157 | 2395 | 1121 | 3972 |
Changes in Working Capital | -92598 | -112036 | -84156 | -66267 | -116278 |
Cash From Investing Activities | -106340 | -67306 | -14042 | -33248 | -205234 |
Capital Expenditures | -137861 | -100127 | -50628 | -32401 | -116216 |
Other Investing Cash Flow Items, Total | 31521 | 32821 | 36586 | -847 | -89018 |
Cash From Financing Activities | 2542 | 29019 | 5508 | 44419 | 89222 |
Financing Cash Flow Items | -22842 | -19782 | -19304 | -3902 | -14873 |
Total Cash Dividends Paid | -24161 | -24161 | -12560 | -12560 | -20527 |
Issuance (Retirement) of Stock, Net | -10018 | -4993 | -6 | -3 | -10031 |
Issuance (Retirement) of Debt, Net | 59563 | 77955 | 37378 | 60884 | 134653 |
Foreign Exchange Effects | 7715 | 6459 | 13731 | 9187 | 8593 |
Net Change in Cash | 5158 | 12256 | 27108 | 9716 | -14835 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Mitsui Chemicals, Inc. Company profile
About Mitsui Chemicals, Inc.
Mitsui Chemicals, Inc. is a chemical manufacturer mainly engaged in the manufacture and sale of mobility, healthcare, food & packaging and basic materials. The Company operates in four business segments. The Mobility segment is engaged in the manufacture and sale of elastomers, functional compounds, functional polymers and polypropylene compounds. The Healthcare segment is engaged in the manufacture and sale of vision care materials, nonwoven fabrics, dental materials and personal care materials. The Food & Packaging segment is engaged in the manufacture and sale of coatings and functional materials, functional films, sheets and pesticides. The Basic Material segment is engaged in the manufacture and sale of petrochemical raw materials such as ethylene and propylene, polyethylene, catalyst, phenol, high purity terephthalic acid, pet resin, polyurethane material and industrial chemicals.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Mitsui Chemicals, Inc. revenues increased 36% to Y1.165T. Net income increased from Y33B to Y100.07B. Revenues reflect Mobility segment increase of 34% to Y296.95B, Food & Packing business segment increase of 19% to Y165.79B. Net income benefited from Equity in Loss of Affiliates increase from Y950M to Y21.98B (income), Other Operating Income increase of 85% to Y2.2B (income).
Equity composition
FY'94-02, FY'04-'06 1&3Q WAS & O/S were estimated. An increase in o/s in FY'98 due to the merger. FY'08 1Q & 3Q WAS was estimated and used for O/S.
Industry: | Commodity Chemicals (NEC) |
東京ミッドタウン八重洲 八重洲セントラルタワー
八重洲2-2-1
CHUO-KU
TOKYO-TO 104-0028
JP
Income Statement
- Annual
- Quarterly
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com